For Patients
If you are thinking about taking part in a clinical trial, be sure to ask your doctor if there is a trial you can join.
Find a TrialFor Investigators
Investigators are responsible for supervising the proper handling, administration, storage, and destruction of investigational agents (ie, drug accountability).
Learn MoreFeatured Trials
NCT06312137
A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery
NCT05879926
NRG-BR009 A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score
NCT06337318
S2308 Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma
NCT05561387
S2209 A Phase III Randomized Trial For Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail Or In A Subset of “Intermediate Fit” Comparing Upfront Three-Drug Induction Regimens Followed by Double- or Single-Agent Maintenance
Clinical Trial Questions?
Call 501-686-8288 or email CancerClinicalTrials@uams.edu